The presentation describes how the deciphering of the Phaeodactylum genome has been instrumental in allowing a wide range of advances aimed at the commercial application of Phaeodactylum and the molecules it can synthesize, such as fucoxanthin, omega-3 fatty acids, and steroids. These advances are enabled from the advanced understanding of the metabolism of this species derived from studies of its genome.